{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:38:17Z","timestamp":1790753897630,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,10,5]],"date-time":"2014-10-05T00:00:00Z","timestamp":1412467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,10,5]],"date-time":"2014-10-05T00:00:00Z","timestamp":1412467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1038\/nchembio.1650","type":"journal-article","created":{"date-parts":[[2014,10,5]],"date-time":"2014-10-05T23:12:38Z","timestamp":1412550758000},"page":"950-956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice"],"prefix":"10.1038","volume":"10","author":[{"given":"Marco","family":"Cavallari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Stallforth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Kalinichenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominea C K","family":"Rathwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M A","family":"Gronewold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Adibekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Landmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H","family":"Seeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"De Libero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,5]]},"reference":[{"key":"BFnchembio1650_CR1","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1128\/IAI.70.9.4977-4986.2002","volume":"70","author":"Q Chang","year":"2002","unstructured":"Chang, Q., Zhong, Z., Lees, A., Pekna, M. & Pirofski, L. Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci. Infect. Immun. 70, 4977\u20134986 (2002).","journal-title":"Infect. Immun."},{"key":"BFnchembio1650_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1367-5931(98)80035-5","volume":"2","author":"KJ Yarema","year":"1998","unstructured":"Yarema, K.J. & Bertozzi, C.R. Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents. Curr. Opin. Chem. Biol. 2, 49\u201361 (1998).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"BFnchembio1650_CR3","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO;2-I","volume":"39","author":"SJ Danishefsky","year":"2000","unstructured":"Danishefsky, S.J. & Allen, J.R. From the laboratory to the clinic: a retrospective on fully synthetic carbohydrate-based anticancer vaccines frequently used abbreviations are listed in the appendix. Angew. Chem. Int. Edn Engl. 39, 836\u2013863 (2000).","journal-title":"Angew. Chem. Int. Edn Engl."},{"key":"BFnchembio1650_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nature00937","volume":"418","author":"L Schofield","year":"2002","unstructured":"Schofield, L., Hewitt, M.C., Evans, K., Siomos, M.A. & Seeberger, P.H. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418, 785\u2013789 (2002).","journal-title":"Nature"},{"key":"BFnchembio1650_CR5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1126\/science.1095209","volume":"305","author":"V Verez-Bencomo","year":"2004","unstructured":"Verez-Bencomo, V. et al. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science 305, 522\u2013525 (2004).","journal-title":"Science"},{"key":"BFnchembio1650_CR6","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1440-1711.2005.01350.x","volume":"83","author":"SF Slovin","year":"2005","unstructured":"Slovin, S.F., Keding, S.J. & Ragupathi, G. Carbohydrate vaccines as immunotherapy for cancer. Immunol. Cell Biol. 83, 418\u2013428 (2005).","journal-title":"Immunol. Cell Biol."},{"key":"BFnchembio1650_CR7","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1016\/j.febslet.2006.03.053","volume":"580","author":"JF Vliegenthart","year":"2006","unstructured":"Vliegenthart, J.F. Carbohydrate based vaccines. FEBS Lett. 580, 2945\u20132950 (2006).","journal-title":"FEBS Lett."},{"key":"BFnchembio1650_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nchembio.2007.25","volume":"3","author":"S Ingale","year":"2007","unstructured":"Ingale, S., Wolfert, M.A., Gaekwad, J., Buskas, T. & Boons, G.J. Robust immune responses elicited by a fully synthetic three-component vaccine. Nat. Chem. Biol. 3, 663\u2013667 (2007).","journal-title":"Nat. Chem. Biol."},{"key":"BFnchembio1650_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cbpa.2009.05.127","volume":"13","author":"M-L Hecht","year":"2009","unstructured":"Hecht, M.-L., Stallforth, P., Silva, D.V., Adibekian, A. & Seeberger, P.H. Recent advances in carbohydrate-based vaccines. Curr. Opin. Chem. Biol. 13, 354\u2013359 (2009).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"BFnchembio1650_CR10","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.4049\/jimmunol.0803141","volume":"182","author":"A Phalipon","year":"2009","unstructured":"Phalipon, A. et al. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection. J. Immunol. 182, 2241\u20132247 (2009).","journal-title":"J. Immunol."},{"key":"BFnchembio1650_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrd3012","volume":"9","author":"RD Astronomo","year":"2010","unstructured":"Astronomo, R.D. & Burton, D.R. Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat. Rev. Drug Discov. 9, 308\u2013324 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnchembio1650_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1099\/00222615-47-7-563","volume":"47","author":"D Goldblatt","year":"1998","unstructured":"Goldblatt, D. Recent developments in bacterial conjugate vaccines. J. Med. Microbiol. 47, 563\u2013567 (1998).","journal-title":"J. Med. Microbiol."},{"key":"BFnchembio1650_CR13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.4049\/jimmunol.0900238","volume":"183","author":"J Colino","year":"2009","unstructured":"Colino, J. et al. Parameters underlying distinct T cell\u2013dependent polysaccharide-specific IgG responses to an intact Gram-positive bacterium versus a soluble conjugate vaccine. J. Immunol. 183, 1551\u20131559 (2009).","journal-title":"J. Immunol."},{"key":"BFnchembio1650_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","volume":"4","author":"D Bogaert","year":"2004","unstructured":"Bogaert, D., De Groot, R. & Hermans, P.W.M. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4, 144\u2013154 (2004).","journal-title":"Lancet Infect. Dis."},{"key":"BFnchembio1650_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","volume":"11","author":"E Miller","year":"2011","unstructured":"Miller, E., Andrews, N.J., Waight, P.A., Slack, M.P. & George, R.C. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect. Dis. 11, 760\u2013768 (2011).","journal-title":"Lancet Infect. Dis."},{"key":"BFnchembio1650_CR16","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","volume":"378","author":"DM Weinberger","year":"2011","unstructured":"Weinberger, D.M., Malley, R. & Lipsitch, M. Serotype replacement in disease after pneumococcal vaccination. Lancet 378, 1962\u20131973 (2011).","journal-title":"Lancet"},{"key":"BFnchembio1650_CR17","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.vaccine.2011.12.119","volume":"30","author":"DR Johnson","year":"2012","unstructured":"Johnson, D.R., D\u2032Onise, K., Holland, R.A., Raupach, J.C.A. & Koehler, A.P. Pneumococcal disease in South Australia: vaccine success but no time for complacency. Vaccine 30, 2206\u20132211 (2012).","journal-title":"Vaccine"},{"key":"BFnchembio1650_CR18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/j.1651-2227.2010.01914.x","volume":"99","author":"C Alexandre","year":"2010","unstructured":"Alexandre, C. et al. Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement. Acta Paediatr. 99, 1686\u20131690 (2010).","journal-title":"Acta Paediatr."},{"key":"BFnchembio1650_CR19","doi-asserted-by":"publisher","first-page":"6686","DOI":"10.1016\/j.vaccine.2011.06.091","volume":"29","author":"KR Tyo","year":"2011","unstructured":"Tyo, K.R. et al. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines. Vaccine 29, 6686\u20136694 (2011).","journal-title":"Vaccine"},{"key":"BFnchembio1650_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/jps.10296","volume":"92","author":"DT Brandau","year":"2003","unstructured":"Brandau, D.T., Jones, L.S., Wiethoff, C.M., Rexroad, J. & Middaugh, C.R. Thermal stability of vaccines. J. Pharm. Sci. 92, 218\u2013231 (2003).","journal-title":"J. Pharm. Sci."},{"key":"BFnchembio1650_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/jama.2009.975","volume":"302","author":"EJM van Gils","year":"2009","unstructured":"van Gils, E.J.M. et al. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial. J. Am. Med. Assoc. 302, 159\u2013167 (2009).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnchembio1650_CR22","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1128\/CVI.00117-10","volume":"17","author":"FM Russell","year":"2010","unstructured":"Russell, F.M. et al. Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster. Clin. Vaccine Immunol. 17, 1970\u20131976 (2010).","journal-title":"Clin. Vaccine Immunol."},{"key":"BFnchembio1650_CR23","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","volume":"278","author":"T Kawano","year":"1997","unstructured":"Kawano, T. et al. CD1d-restricted and TCR-mediated activation of v\u03b114 NKT cells by glycosylceramides. Science 278, 1626\u20131629 (1997).","journal-title":"Science"},{"key":"BFnchembio1650_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1084\/jem.20011889","volume":"195","author":"G Gonzalez-Aseguinolaza","year":"2002","unstructured":"Gonzalez-Aseguinolaza, G. et al. Natural killer T cell ligand \u03b1-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195, 617\u2013624 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnchembio1650_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nri2451","volume":"9","author":"V Cerundolo","year":"2009","unstructured":"Cerundolo, V., Silk, J.D., Masri, S.H. & Salio, M. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9, 28\u201338 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnchembio1650_CR26","doi-asserted-by":"publisher","first-page":"e37991","DOI":"10.1371\/journal.pone.0037991","volume":"7","author":"EC Reilly","year":"2012","unstructured":"Reilly, E.C. et al. Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection. PLoS ONE 7, e37991 (2012).","journal-title":"PLoS ONE"},{"key":"BFnchembio1650_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1182\/blood-2012-06-435503","volume":"121","author":"J Richter","year":"2013","unstructured":"Richter, J. et al. Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma. Blood 121, 423\u2013430 (2013).","journal-title":"Blood"},{"key":"BFnchembio1650_CR28","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10875-012-9697-9","volume":"32","author":"K Nagato","year":"2012","unstructured":"Nagato, K. et al. Accumulation of activated invariant natural killer T cells in the tumor microenvironment after \u03b1-galactosylceramide\u2013pulsed antigen presenting cells. J. Clin. Immunol. 32, 1071\u20131081 (2012).","journal-title":"J. Clin. Immunol."},{"key":"BFnchembio1650_CR29","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1021\/ol025565+","volume":"4","author":"X-T Zhou","year":"2002","unstructured":"Zhou, X.-T. et al. Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6\u201d-amino-6\u201d-deoxy-galactosylceramides. Org. Lett. 4, 1267\u20131270 (2002).","journal-title":"Org. Lett."},{"key":"BFnchembio1650_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0141-0229(82)90109-0","volume":"4","author":"J Kohn","year":"1982","unstructured":"Kohn, J. & Wilchek, M. Mechanism of activation of Sepharose and Sephadex by cyanogen bromide. Enzyme Microb. Technol. 4, 161\u2013163 (1982).","journal-title":"Enzyme Microb. Technol."},{"key":"BFnchembio1650_CR31","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0264-410X(98)00139-X","volume":"16","author":"RT Coughlin","year":"1998","unstructured":"Coughlin, R.T. et al. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine 16, 1761\u20131767 (1998).","journal-title":"Vaccine"},{"key":"BFnchembio1650_CR32","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.4049\/jimmunol.170.12.6158","volume":"170","author":"E Saeland","year":"2003","unstructured":"Saeland, E. et al. Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J. Immunol. 170, 6158\u20136164 (2003).","journal-title":"J. Immunol."},{"key":"BFnchembio1650_CR33","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.4049\/jimmunol.163.9.4647","volume":"163","author":"C Carnaud","year":"1999","unstructured":"Carnaud, C. et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647\u20134650 (1999).","journal-title":"J. Immunol."},{"key":"BFnchembio1650_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1084\/jem.20030324","volume":"198","author":"S Fujii","year":"2003","unstructured":"Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. & Steinman, R.M. Activation of natural killer T cells by \u03b1-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198, 267\u2013279 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnchembio1650_CR35","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.4049\/jimmunol.1002163","volume":"185","author":"MM Tomayko","year":"2010","unstructured":"Tomayko, M.M., Steinel, N.C., Anderson, S.M. & Shlomchik, M.J. Cutting edge: Hierarchy of maturity of murine memory B cell subsets. J. Immunol. 185, 7146\u20137150 (2010).","journal-title":"J. Immunol."},{"key":"BFnchembio1650_CR36","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<2981::AID-IMMU2981>3.0.CO;2-D","volume":"28","author":"Y Yamashita","year":"1998","unstructured":"Yamashita, Y. et al. CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur. J. Immunol. 28, 2981\u20132990 (1998).","journal-title":"Eur. J. Immunol."},{"key":"BFnchembio1650_CR37","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1084\/jem.20062571","volume":"204","author":"SM Anderson","year":"2007","unstructured":"Anderson, S.M., Tomayko, M.M., Ahuja, A., Haberman, A.M. & Shlomchik, M.J. New markers for murine memory B cells that define mutated and unmutated subsets. J. Exp. Med. 204, 2103\u20132114 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnchembio1650_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ni.2166","volume":"13","author":"PP Chang","year":"2012","unstructured":"Chang, P.P. et al. Identification of Bcl-6\u2013dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat. Immunol. 13, 35\u201343 (2012).","journal-title":"Nat. Immunol."},{"key":"BFnchembio1650_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","volume":"25","author":"A Bendelac","year":"2007","unstructured":"Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297\u2013336 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnchembio1650_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0264-410X(98)00162-5","volume":"17","author":"A Fattom","year":"1999","unstructured":"Fattom, A. et al. Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines. Vaccine 17, 126\u2013133 (1999).","journal-title":"Vaccine"},{"key":"BFnchembio1650_CR41","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/nm.2535","volume":"17","author":"FY Avci","year":"2011","unstructured":"Avci, F.Y., Li, X., Tsuji, M. & Kasper, D.L. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat. Med. 17, 1602\u20131609 (2011).","journal-title":"Nat. Med."},{"key":"BFnchembio1650_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/ni.2172","volume":"13","author":"IL King","year":"2012","unstructured":"King, I.L. et al. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21\u2013dependent manner. Nat. Immunol. 13, 44\u201350 (2012).","journal-title":"Nat. Immunol."},{"key":"BFnchembio1650_CR43","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/eji.201344399","volume":"44","author":"P Dellabona","year":"2014","unstructured":"Dellabona, P., Abrignani, S. & Casorati, G. iNKT-cell help to B cells: a cooperative job between innate and adaptive immune responses. Eur. J. Immunol. 44, 2230\u20132237 (2014).","journal-title":"Eur. J. Immunol."},{"key":"BFnchembio1650_CR44","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.4049\/jimmunol.1103501","volume":"188","author":"E Tonti","year":"2012","unstructured":"Tonti, E. et al. Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4+ T cell help. J. Immunol. 188, 3217\u20133222 (2012).","journal-title":"J. Immunol."},{"key":"BFnchembio1650_CR45","doi-asserted-by":"publisher","first-page":"16097","DOI":"10.1073\/pnas.1303218110","volume":"110","author":"L Bai","year":"2013","unstructured":"Bai, L. et al. Natural killer T (NKT)\u2013B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides. Proc. Natl. Acad. Sci. USA 110, 16097\u201316102 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio1650_CR46","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1084\/jem.188.8.1521","volume":"188","author":"L Brossay","year":"1998","unstructured":"Brossay, L. et al. CD1d-mediated recognition of an \u03b1-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521\u20131528 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnchembio1650_CR47","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1016\/j.bmc.2007.05.044","volume":"15","author":"L Franchini","year":"2007","unstructured":"Franchini, L. et al. Synthesis and evaluation of human T cell stimulating activity of an alpha-sulfatide analogue. Bioorg. Med. Chem. 15, 5529\u20135536 (2007).","journal-title":"Bioorg. Med. Chem."},{"key":"BFnchembio1650_CR48","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1002\/eji.201040619","volume":"40","author":"E Kyriakakis","year":"2010","unstructured":"Kyriakakis, E. et al. Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis. Eur. J. Immunol. 40, 3268\u20133279 (2010).","journal-title":"Eur. J. Immunol."},{"key":"BFnchembio1650_CR49","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1126\/science.275.5302.977","volume":"275","author":"ST Smiley","year":"1997","unstructured":"Smiley, S.T., Kaplan, M.H. & Grusby, M.J. Immunoglobulin E production in the absence of interleukin-4\u2013secreting CD1-dependent cells. Science (New York, N.Y.) 275, 977\u2013979 (1997).","journal-title":"Science (New York, N.Y.)"},{"key":"BFnchembio1650_CR50","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1073\/pnas.1108809108","volume":"108","author":"F Facciotti","year":"2011","unstructured":"Facciotti, F. et al. Fine tuning by human CD1e of lipid-specific immune responses. Proc. Natl. Acad. Sci. USA 108, 14228\u201314233 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nchembio.1650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.1650","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.1650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T02:00:53Z","timestamp":1689559253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,5]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["BFnchembio1650"],"URL":"https:\/\/doi.org\/10.1038\/nchembio.1650","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,5]]},"assertion":[{"value":"26 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.M.A.G. is an employer of SAW Instruments, Bonn. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}